First American Bank Has Increased Its Ibm (IBM) Stake; Capital Planning Advisors Decreased Bristol Myers Squibb Co (BMY) Stake by $372,708

June 22, 2018 - By Dolores Ford

Bristol-Myers Squibb Company (NYSE:BMY) Logo

Ken Heebner decreased its stake in Bristol Myers Squibb Co (BMY) by 16.73% based on its latest 2018Q1 regulatory filing with the SEC. Capital Planning Advisors Llc sold 5,916 shares as the company’s stock declined 23.11% with the market. The hedge fund run by Ken Heebner held 29,450 shares of the major pharmaceuticals company at the end of 2018Q1, valued at $1.86M, down from 35,366 at the end of the previous reported quarter. Capital Planning Advisors Llc who had been investing in Bristol Myers Squibb Co for a number of months, seems to be less bullish one the $90.13B market cap company. The stock increased 2.22% or $1.2 during the last trading session, reaching $55.14. About 10.26M shares traded or 14.93% up from the average. Bristol-Myers Squibb Company (NYSE:BMY) has declined 2.98% since June 22, 2017 and is downtrending. It has underperformed by 15.55% the S&P500. Some Historical BMY News: 16/04/2018 – BRISTOL, JANSSEN EXPECT BMS-986177 TO START PHASE 2 IN 2H; 18/04/2018 – FDA ACCEPTS BRISTOL-MYERS’ OPDIVO FOR PRIORITY REVIEW IN SCLC; 14/03/2018 – #AACR18 Immuno-oncology combo session; 26/03/2018 – Bristol-Myers Squibb Receives Positive CHMP Opinion Recommending Approval of Opdivo Four-Week Dosing Schedule for Advanced Melanoma and Previously Treated Renal Cell Carcinoma; 03/04/2018 – Rhode Island DoA: Bristol Town Council Tue, 4/3/2018, 7:30 PM; 16/04/2018 – Heard on the Street: Bristol-Myers has Farther to Fall; 23/04/2018 – Rhode Island DoA: Bristol Warren Regional School District Mon, 4/23/2018, 7:45 PM; 18/05/2018 – FDA – MERCK, GENENTECH HAVE STOPPED ENROLLING PATIENTS WHOSE TUMORS HAVE PD-L1 LOW STATUS TO KEYTRUDA/TECENTRIQ MONOTHERAPY ARMS PER DMCS’ RECOMMENDATIONS; 13/04/2018 – BMY: OPDIVO DEMONSTRATES SUPERIOR SURVIVAL BENEFIT; 16/04/2018 – BRISTOL-MYERS SQUIBB – IN PHASE 3 CHECKMATE -214 TRIAL, OPDIVO + YERVOY ALSO DELIVERED DURABLE RESPONSES, WITH HIGHER OBJECTIVE RESPONSE RATE VS SUNITINIB

First American Bank increased its stake in Ibm Corp (IBM) by 57.65% based on its latest 2018Q1 regulatory filing with the SEC. First American Bank bought 5,619 shares as the company’s stock declined 9.42% with the market. The institutional investor held 15,365 shares of the computer manufacturing company at the end of 2018Q1, valued at $2.36M, up from 9,746 at the end of the previous reported quarter. First American Bank who had been investing in Ibm Corp for a number of months, seems to be bullish on the $129.69B market cap company. The stock increased 0.02% or $0.03 during the last trading session, reaching $141.28. About 5.89M shares traded or 28.12% up from the average. International Business Machines Corporation (NYSE:IBM) has declined 6.24% since June 22, 2017 and is downtrending. It has underperformed by 18.81% the S&P500. Some Historical IBM News: 17/04/2018 – IBM: Tax Charge Is in Addition to Provisional $5.5 Billion Reported in 4Q; 06/03/2018 – BayCare Hospitals Named Among Nation’s 100 Top Hospitals by IBM Watson Health; 05/04/2018 – Rabobank Desensitizes Client Data for GDPR and DevOps with IBM; 16/05/2018 – Qualtrics Announces Strategic Partnership with IBM; 21/03/2018 – V3: IBM teams with Nvidia to use GPUs to boost AI research; 19/04/2018 – IBM Bond Trading 2x Average; Clients Net Buyers; 19/03/2018 – Radiant Logic Highlights RadiantOne Federated Identity Platform at IBM Think; 17/04/2018 – After-hours buzz: IBM, ISRG, UAL & more; 28/05/2018 – The chief of IBM’s supercomputer unit likes Elon Musk but ‘hates’ A.I. scaremongering; 10/04/2018 – McAfee and IBM Security Extend Partnership With Key Areas of Product Integrations

Investors sentiment decreased to 0.83 in 2018 Q1. Its down 0.11, from 0.94 in 2017Q4. It dropped, as 64 investors sold BMY shares while 573 reduced holdings. 111 funds opened positions while 418 raised stakes. 1.12 billion shares or 1.08% more from 1.11 billion shares in 2017Q4 were reported. Apg Asset Mgmt Nv invested in 0.21% or 2.13 million shares. Glacier Peak Cap Ltd stated it has 0.77% of its portfolio in Bristol-Myers Squibb Company (NYSE:BMY). Umb Bankshares N A Mo holds 0.23% or 112,225 shares in its portfolio. Alpha Cubed Invs Ltd Liability Corp invested in 0.08% or 10,020 shares. Dixon Hubard Feinour And Brown Va has invested 1.14% in Bristol-Myers Squibb Company (NYSE:BMY). Moreover, Bremer Tru Natl Association has 0.19% invested in Bristol-Myers Squibb Company (NYSE:BMY). New York-based D E Shaw & has invested 0.66% in Bristol-Myers Squibb Company (NYSE:BMY). The Massachusetts-based Boston Family Office Lc has invested 0.31% in Bristol-Myers Squibb Company (NYSE:BMY). Associated Banc holds 0.46% or 128,032 shares in its portfolio. Moreover, Cambiar Limited Liability Corporation has 0.56% invested in Bristol-Myers Squibb Company (NYSE:BMY) for 559,967 shares. Osterweis Cap Mgmt Incorporated holds 14,523 shares. Japan-based Tokio Marine Asset has invested 0.8% in Bristol-Myers Squibb Company (NYSE:BMY). Moreover, Smithfield Tru Co has 0.18% invested in Bristol-Myers Squibb Company (NYSE:BMY). Hanseatic Mngmt invested in 940 shares or 0.06% of the stock. Massachusetts-based Natixis Advisors Ltd Partnership has invested 0.12% in Bristol-Myers Squibb Company (NYSE:BMY).

More notable recent Bristol-Myers Squibb Company (NYSE:BMY) news were published by: Seekingalpha.com which released: “Merck up 2% premarket on positive Keytruda data; Bristol-Myers down 2%” on June 04, 2018, also Seekingalpha.com with their article: “Nektar down 24% premarket on Opdivo + NKTR-214 data” published on June 04, 2018, Seekingalpha.com published: “Bristol-Myers’ Opdivo + Yervoy beats Pfizer’s Sutent in late-stage RCC study” on June 01, 2018. More interesting news about Bristol-Myers Squibb Company (NYSE:BMY) were released by: Seekingalpha.com and their article: “Under Armour Is A Winner – Cramer’s Lightning Round (6/20/18)” published on June 21, 2018 as well as Seekingalpha.com‘s news article titled: “Bristol-Myers Top NASH Contenders” with publication date: June 12, 2018.

Since April 30, 2018, it had 1 insider buy, and 0 selling transactions for $249,948 activity.

Analysts await Bristol-Myers Squibb Company (NYSE:BMY) to report earnings on July, 26. They expect $0.87 EPS, up 17.57% or $0.13 from last year’s $0.74 per share. BMY’s profit will be $1.42 billion for 15.84 P/E if the $0.87 EPS becomes a reality. After $0.94 actual EPS reported by Bristol-Myers Squibb Company for the previous quarter, Wall Street now forecasts -7.45% negative EPS growth.

Among 22 analysts covering Bristol-Myers Squibb Company (NYSE:BMY), 6 have Buy rating, 2 Sell and 14 Hold. Therefore 27% are positive. Bristol-Myers Squibb Company had 87 analyst reports since July 28, 2015 according to SRatingsIntel. Jefferies maintained it with “Hold” rating and $59 target in Thursday, August 27 report. The stock of Bristol-Myers Squibb Company (NYSE:BMY) has “Hold” rating given on Tuesday, March 15 by Jefferies. Barclays Capital maintained the stock with “Equal Weight” rating in Tuesday, December 1 report. Bank of America maintained the stock with “Neutral” rating in Monday, March 5 report. BMO Capital Markets maintained the stock with “Sell” rating in Monday, June 5 report. As per Monday, July 10, the company rating was maintained by Cowen & Co. The firm has “Buy” rating by Leerink Swann given on Thursday, July 27. The rating was maintained by Piper Jaffray on Thursday, October 26 with “Hold”. The firm has “Neutral” rating by Hilliard Lyons given on Monday, May 23. As per Wednesday, December 2, the company rating was upgraded by Guggenheim.

Among 33 analysts covering International Business Machines (NYSE:IBM), 13 have Buy rating, 4 Sell and 16 Hold. Therefore 39% are positive. International Business Machines had 129 analyst reports since July 21, 2015 according to SRatingsIntel. The company was maintained on Tuesday, October 18 by Citigroup. Drexel Hamilton maintained International Business Machines Corporation (NYSE:IBM) rating on Tuesday, April 19. Drexel Hamilton has “Buy” rating and $166 target. Morgan Stanley maintained International Business Machines Corporation (NYSE:IBM) rating on Wednesday, October 18. Morgan Stanley has “Buy” rating and $192.0 target. As per Friday, January 8, the company rating was maintained by Stifel Nicolaus. The stock has “Underweight” rating by Barclays Capital on Wednesday, October 14. On Wednesday, January 4 the stock rating was initiated by Guggenheim with “Neutral”. The firm has “Underperform” rating by Jefferies given on Tuesday, July 19. The rating was maintained by RBC Capital Markets with “Hold” on Thursday, October 12. As per Tuesday, October 20, the company rating was maintained by UBS. The stock has “Buy” rating by Stifel Nicolaus on Friday, January 19.

More notable recent International Business Machines Corporation (NYSE:IBM) news were published by: Seekingalpha.com which released: “Mass layoffs at IBM Watson Health?” on May 31, 2018, also Prnewswire.com with their article: “IBM Acquires Oniqua, Strengthens Leading IoT Capabilities to Help Businesses Proactively Maintain Vital Assets” published on June 15, 2018, Investorplace.com published: “5 Cheap Technology Stocks Amid the Sector’s Weakness” on June 22, 2018. More interesting news about International Business Machines Corporation (NYSE:IBM) were released by: Fool.com and their article: “7 Years After Watson, IBM’s AI Turns Heads Again” published on June 20, 2018 as well as Seekingalpha.com‘s news article titled: “IBM: Unimpressive And Overpriced” with publication date: June 05, 2018.

First American Bank, which manages about $1.32B US Long portfolio, decreased its stake in Edwards Lifesciences Corp Com (NYSE:EW) by 2,381 shares to 59,481 shares, valued at $8.30M in 2018Q1, according to the filing. It also reduced its holding in Vanguard by 14,140 shares in the quarter, leaving it with 252,274 shares, and cut its stake in Federated (FMUSX).

Since January 31, 2018, it had 1 insider purchase, and 2 selling transactions for $2.69 million activity. The insider Clementi Erich sold 13,000 shares worth $2.01 million. Gherson Diane J had sold 5,000 shares worth $780,000.

Investors sentiment increased to 1.11 in 2018 Q1. Its up 0.08, from 1.03 in 2017Q4. It increased, as 60 investors sold IBM shares while 560 reduced holdings. 117 funds opened positions while 570 raised stakes. 501.15 million shares or 0.58% less from 504.07 million shares in 2017Q4 were reported. Fairpointe Capital Limited Co stated it has 0.01% of its portfolio in International Business Machines Corporation (NYSE:IBM). Jarislowsky Fraser Limited invested in 54,497 shares or 0.05% of the stock. Insight 2811 accumulated 5,900 shares or 0.65% of the stock. Wade G W Inc has 0.2% invested in International Business Machines Corporation (NYSE:IBM) for 11,237 shares. Bangor State Bank invested 0.2% of its portfolio in International Business Machines Corporation (NYSE:IBM). Gabelli Funds Limited Liability Co holds 0.06% or 67,000 shares in its portfolio. Rafferty Asset Management Llc has 33,105 shares. Northern Corporation holds 0.43% or 10.83 million shares in its portfolio. Catalyst Lc invested 0.02% in International Business Machines Corporation (NYSE:IBM). Beese Fulmer Inv Mngmt has 0.87% invested in International Business Machines Corporation (NYSE:IBM) for 25,810 shares. Mycio Wealth Limited reported 6,112 shares or 0.11% of all its holdings. Amer Assets Invest Mngmt reported 18,000 shares. Patten Gp reported 0.18% in International Business Machines Corporation (NYSE:IBM). Cedar Hill Associate Lc holds 0.06% or 1,899 shares in its portfolio. Sumitomo Mitsui Trust Holdings owns 0.56% invested in International Business Machines Corporation (NYSE:IBM) for 2.83 million shares.

Bristol-Myers Squibb Company (NYSE:BMY) Institutional Positions Chart

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>